{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:12:01Z","timestamp":1793045521742,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03813-2","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:02:00Z","timestamp":1745499720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic impact of albumin-bilirubin score in predicting the long-term survival of distal cholangiocarcinoma after radical surgery"],"prefix":"10.1186","volume":"23","author":[{"given":"Jin-Can","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"3813_CR1","doi-asserted-by":"publisher","unstructured":"Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013 Dec;145(6):1215\u201329. Epub 2013\/10\/22. https:\/\/doi.org\/10.1053\/j.gastro.2013.10.013. Cited in: Pubmed; PMID 24140396.","DOI":"10.1053\/j.gastro.2013.10.013"},{"key":"3813_CR2","doi-asserted-by":"publisher","unstructured":"Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996 Oct;224(4):463\u201373; discussion 473\u20135. Epub 1996\/10\/01. https:\/\/doi.org\/10.1097\/00000658-199610000-00005. Cited in: Pubmed; PMID 8857851.","DOI":"10.1097\/00000658-199610000-00005"},{"key":"3813_CR3","doi-asserted-by":"publisher","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019 May;39 Suppl 1:19\u201331. Epub 2019\/03\/10. https:\/\/doi.org\/10.1111\/liv.14095. Cited in: Pubmed; PMID 30851228.","DOI":"10.1111\/liv.14095"},{"key":"3813_CR4","doi-asserted-by":"publisher","unstructured":"Zhou Y, Liu S, Wu L, Wan T. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian J Surg. 2017 Apr;40(2):129\u2013138. Epub 2015\/09\/05. https:\/\/doi.org\/10.1016\/j.asjsur.2015.07.002. Cited in: Pubmed; PMID 26337377.","DOI":"10.1016\/j.asjsur.2015.07.002"},{"key":"3813_CR5","doi-asserted-by":"publisher","unstructured":"Strijker M, Belkouz A, van der Geest LG, van Gulik TM, van Hooft JE, de Meijer VE, Haj Mohammad N, de Reuver PR, Verheij J, de Vos-Geelen J, Wilmink JW, Groot Koerkamp B, Klumpen HJ, Besselink MG, Dutch Pancreatic Cancer G. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncol. 2019 Jul;58(7):1048\u20131055. Epub 2019\/03\/26. https:\/\/doi.org\/10.1080\/0284186X.2019.1590634. Cited in: Pubmed; PMID 30907207.","DOI":"10.1080\/0284186X.2019.1590634"},{"key":"3813_CR6","doi-asserted-by":"publisher","unstructured":"Rizzo A, Brandi G. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care. Expert Rev Gastroenterol Hepatol. 2021 May;15(5):483\u2013485. Epub 2020\/12\/15. https:\/\/doi.org\/10.1080\/17474124.2021.1864325. Cited in: Pubmed; PMID 33307876.","DOI":"10.1080\/17474124.2021.1864325"},{"key":"3813_CR7","doi-asserted-by":"publisher","unstructured":"Carloni R, Rizzo A, Ricci AD, Federico AD, De Luca R, Guven DC, Yalcin S, Brandi G. Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine. Transl Oncol. 2022 Nov;25:101514. Epub 2022\/08\/18. https:\/\/doi.org\/10.1016\/j.tranon.2022.101514. Cited in: Pubmed; PMID 35977458.","DOI":"10.1016\/j.tranon.2022.101514"},{"key":"3813_CR8","doi-asserted-by":"publisher","unstructured":"Rizzo A, Frega G, Ricci AD, Palloni A, Abbati F, S DEL, Deserti M, Tavolari S, Brandi G. Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis. In Vivo. 2020 Mar-Apr;34(2):479\u2013488. Epub 2020\/03\/01. https:\/\/doi.org\/10.21873\/invivo.11798. Cited in: Pubmed; PMID 32111744.","DOI":"10.21873\/invivo.11798"},{"key":"3813_CR9","doi-asserted-by":"publisher","unstructured":"Narimatsu H, Yaguchi YT. The Role of Diet and Nutrition in Cancer: Prevention, Treatment, and Survival. Nutrients. 2022 Aug 14;14(16). Epub 2022\/08\/27. https:\/\/doi.org\/10.3390\/nu14163329. Cited in: Pubmed; PMID 36014835.","DOI":"10.3390\/nu14163329"},{"key":"3813_CR10","doi-asserted-by":"publisher","unstructured":"Sahin TK, Ayasun R, Rizzo A, Guven DC. Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2024 Oct 31;16(21). Epub 2024\/11\/13. https:\/\/doi.org\/10.3390\/cancers16213689. Cited in: Pubmed; PMID 39518127.","DOI":"10.3390\/cancers16213689"},{"key":"3813_CR11","doi-asserted-by":"publisher","unstructured":"Hiraoka A, Kumada T, Michitaka K, Kudo M. Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients. Liver Cancer. 2019 Oct;8(5):312\u2013325. Epub 2019\/11\/27. https:\/\/doi.org\/10.1159\/000494844. Cited in: Pubmed; PMID 31768342.","DOI":"10.1159\/000494844"},{"key":"3813_CR12","doi-asserted-by":"publisher","unstructured":"Matsukane R, Watanabe H, Hata K, Suetsugu K, Tsuji T, Egashira N, Nakanishi Y, Okamoto I, Ieiri I. Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy. Sci Rep. 2021 Jul 23;11(1):15057. Epub 2021\/07\/25. https:\/\/doi.org\/10.1038\/s41598-021-94336-9. Cited in: Pubmed; PMID 34301991.","DOI":"10.1038\/s41598-021-94336-9"},{"key":"3813_CR13","doi-asserted-by":"publisher","unstructured":"Tang YY, Zhao YN, Zhang T, Chen ZY, Ma XL. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma. World J Gastroenterol. 2021 Nov 7;27(41):7173\u20137189. Epub 2021\/12\/11. https:\/\/doi.org\/10.3748\/wjg.v27.i41.7173. Cited in: Pubmed; PMID 34887636.","DOI":"10.3748\/wjg.v27.i41.7173"},{"key":"3813_CR14","doi-asserted-by":"publisher","unstructured":"Jiang S, Zhao R, Li Y, Han X, Liu Z, Ge W, Dong Y, Han W. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database. Sci Rep. 2018 May 21;8(1):7940. Epub 2018\/05\/23. https:\/\/doi.org\/10.1038\/s41598-018-26145-6. Cited in: Pubmed; PMID 29786691.","DOI":"10.1038\/s41598-018-26145-6"},{"key":"3813_CR15","doi-asserted-by":"publisher","unstructured":"Liu Q, Li J, Liu F, Yang W, Ding J, Chen W, Wei Y, Li B, Zheng L. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Cancer Imaging. 2020 Nov 16;20(1):82. Epub 2020\/11\/18. https:\/\/doi.org\/10.1186\/s40644-020-00360-9. Cited in: Pubmed; PMID 33198809.","DOI":"10.1186\/s40644-020-00360-9"},{"key":"3813_CR16","doi-asserted-by":"publisher","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A, Palmer D, Yeo W, Mo F, Lai P, Inarrairaegui M, Chan SL, Sangro B, Miksad R, Tada T, Kumada T, Toyoda H. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015 Feb 20;33(6):550\u20138. Epub 2014\/12\/17. https:\/\/doi.org\/10.1200\/JCO.2014.57.9151. Cited in: Pubmed; PMID 25512453.","DOI":"10.1200\/JCO.2014.57.9151"},{"key":"3813_CR17","doi-asserted-by":"publisher","unstructured":"Elmunzer BJ, Maranki JL, Gomez V, Tavakkoli A, Sauer BG, Limketkai BN, Brennan EA, Attridge EM, Brigham TJ, Wang AY. ACG Clinical Guideline: Diagnosis and Management of Biliary Strictures. Am J Gastroenterol. 2023 Mar 1;118(3):405\u2013426. Epub 2023\/03\/03. https:\/\/doi.org\/10.14309\/ajg.0000000000002190. Cited in: Pubmed; PMID 36863037.","DOI":"10.14309\/ajg.0000000000002190"},{"key":"3813_CR18","doi-asserted-by":"publisher","unstructured":"Chiorean EG, Chiaro MD, Tempero MA, Malafa MP, Benson AB, Cardin DB, Christensen JA, Chung V, Czito B, Dillhoff M, Donahue TR, Dotan E, Fountzilas C, Glazer ES, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Masood A, Moravek C, Nakakura EK, Narang AK, Nardo L, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Truty MJ, Vollmer C, Wolff RA, Wolpin BM, Rn BM, Lubin S, Darlow SD. Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Jul;21(7):753\u2013782. Epub 2023\/07\/12. https:\/\/doi.org\/10.6004\/jnccn.2023.0034. Cited in: Pubmed; PMID 37433437.","DOI":"10.6004\/jnccn.2023.0034"},{"key":"3813_CR19","doi-asserted-by":"publisher","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021 Jan 30;397(10272):428\u2013444. Epub 2021\/02\/01. https:\/\/doi.org\/10.1016\/S0140-6736(21)00153-7. Cited in: Pubmed; PMID 33516341.","DOI":"10.1016\/S0140-6736(21)00153-7"},{"key":"3813_CR20","doi-asserted-by":"publisher","unstructured":"Dickson PV, Behrman SW. Distal cholangiocarcinoma. Surg Clin North Am. 2014 Apr;94(2):325\u201342. Epub 2014\/04\/01. https:\/\/doi.org\/10.1016\/j.suc.2013.12.004. Cited in: Pubmed; PMID 24679424.","DOI":"10.1016\/j.suc.2013.12.004"},{"key":"3813_CR21","doi-asserted-by":"publisher","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007 May;245(5):755\u201362. Epub 2007\/04\/26. https:\/\/doi.org\/10.1097\/01.sla.0000251366.62632.d3. Cited in: Pubmed; PMID 17457168.","DOI":"10.1097\/01.sla.0000251366.62632.d3"},{"key":"3813_CR22","doi-asserted-by":"crossref","unstructured":"Ethun CG, Le N, Lopez-Aguiar AG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Russell MC, Maithel SK. Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium. Am Surg. 2017 Jul 1;83(7):679\u2013686. Epub 2017\/07\/26. Cited in: Pubmed; PMID 28738935.","DOI":"10.1177\/000313481708300721"},{"key":"3813_CR23","doi-asserted-by":"publisher","unstructured":"Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, Cho CK. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion. Surg Today. 2014 Oct;44(10):1879\u201386. Epub 2014\/02\/19. https:\/\/doi.org\/10.1007\/s00595-014-0846-z. Cited in: Pubmed; PMID 24535697.","DOI":"10.1007\/s00595-014-0846-z"},{"key":"3813_CR24","doi-asserted-by":"publisher","unstructured":"Terasaki F, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Uesaka K. Use of preoperative controlling nutritional status (CONUT) score as a better prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy. Surg Today. 2021 Mar;51(3):358\u2013365. Epub 2020\/08\/08. https:\/\/doi.org\/10.1007\/s00595-020-02098-0. Cited in: Pubmed; PMID 32761459.","DOI":"10.1007\/s00595-020-02098-0"},{"key":"3813_CR25","doi-asserted-by":"publisher","unstructured":"Kitasato A, Kuroki T. Significance of inflammatory and nutritional markers as prognostic predictors in patients with resected distal cholangiocarcinoma. Asian J Surg. 2021 Dec;44(12):1574\u20131576. Epub 2021\/09\/11. https:\/\/doi.org\/10.1016\/j.asjsur.2021.08.021. Cited in: Pubmed; PMID 34503876.","DOI":"10.1016\/j.asjsur.2021.08.021"},{"key":"3813_CR26","doi-asserted-by":"publisher","unstructured":"Zhang ZQ, Xiong L, Zhou JJ, Miao XY, Li QL, Wen Y, Zou H. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC. World J Surg Oncol. 2018 Oct 16;16(1):208. Epub 2018\/10\/18. https:\/\/doi.org\/10.1186\/s12957-018-1500-9. Cited in: Pubmed; PMID 30326907.","DOI":"10.1186\/s12957-018-1500-9"},{"key":"3813_CR27","doi-asserted-by":"publisher","unstructured":"Mao S, Yu X, Shan Y, Fan R, Wu S, Lu C. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:1355\u20131365. Epub 2021\/11\/23. https:\/\/doi.org\/10.2147\/JHC.S339707. Cited in: Pubmed; PMID 34805014.","DOI":"10.2147\/JHC.S339707"},{"key":"3813_CR28","doi-asserted-by":"publisher","unstructured":"Kudo M. Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma. Liver Cancer. 2022 Jan;11(1):1\u20138. Epub 2022\/03\/01. https:\/\/doi.org\/10.1159\/000521374. Cited in: Pubmed; PMID 35222503.","DOI":"10.1159\/000521374"},{"key":"3813_CR29","doi-asserted-by":"publisher","unstructured":"Wu N, Chen G, Hu H, Pang L, Chen Z. Low pretherapeutic serum albumin as a risk factor for poor outcome in esophageal squamous cell carcinomas. Nutr Cancer. 2015;67(3):481\u20135. Epub 2015\/02\/24. https:\/\/doi.org\/10.1080\/01635581.2015.1004726. Cited in: Pubmed; PMID 25706773.","DOI":"10.1080\/01635581.2015.1004726"},{"key":"3813_CR30","doi-asserted-by":"publisher","unstructured":"Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, Cervera E, Mohar-Betancourt A. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007 Feb;14(2):381\u20139. Epub 2006\/12\/13. https:\/\/doi.org\/10.1245\/s10434-006-9093-x. Cited in: Pubmed; PMID 17160496.","DOI":"10.1245\/s10434-006-9093-x"},{"key":"3813_CR31","doi-asserted-by":"publisher","unstructured":"Peters SJ, Vanhaecke T, Papeleu P, Rogiers V, Haagsman HP, van Norren K. Co-culture of primary rat hepatocytes with rat liver epithelial cells enhances interleukin-6-induced acute-phase protein response. Cell Tissue Res. 2010 Jun;340(3):451\u20137. Epub 2010\/04\/23. https:\/\/doi.org\/10.1007\/s00441-010-0955-y. Cited in: Pubmed; PMID 20411395.","DOI":"10.1007\/s00441-010-0955-y"},{"key":"3813_CR32","doi-asserted-by":"publisher","unstructured":"Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006 Jan;47(1):139\u201348. Epub 2005\/12\/27. https:\/\/doi.org\/10.1053\/j.ajkd.2005.09.014. Cited in: Pubmed; PMID 16377395.","DOI":"10.1053\/j.ajkd.2005.09.014"},{"key":"3813_CR33","doi-asserted-by":"publisher","unstructured":"Shen J, Wen T, Li C, Yan L, Li B, Yang J. The Prognostic Prediction Role of Preoperative Serum Albumin Level in Patients with Intahepatic Cholangiocarcinoma Following Hepatectomy. Dig Dis. 2018;36(4):306\u2013313. Epub 2018\/04\/20. https:\/\/doi.org\/10.1159\/000487479. Cited in: Pubmed; PMID 29672305.","DOI":"10.1159\/000487479"},{"key":"3813_CR34","doi-asserted-by":"publisher","unstructured":"Waghray A, Sobotka A, Marrero CR, Estfan B, Aucejo F, Narayanan Menon KV. Serum albumin predicts survival in patients with hilar cholangiocarcinoma. Gastroenterol Rep (Oxf). 2017 Feb;5(1):62\u201366. Epub 2016\/07\/09. https:\/\/doi.org\/10.1093\/gastro\/gow021. Cited in: Pubmed; PMID 27389416.","DOI":"10.1093\/gastro\/gow021"},{"key":"3813_CR35","doi-asserted-by":"publisher","unstructured":"Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, Furuse J, Saito H, Tsuyuguchi T, Yoshikawa T, Ohta T, Kimura F, Ohta T, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Amano H, Miura F, Japanese Association of Biliary S, Japanese Society of Hepato-Biliary-Pancreatic S, Japan Society of Clinical O. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15(1):25\u201330. Epub 2008\/02\/16. https:\/\/doi.org\/10.1007\/s00534-007-1277-7. Cited in: Pubmed; PMID 18274841.","DOI":"10.1007\/s00534-007-1277-7"},{"key":"3813_CR36","unstructured":"Abdel Wahab M, Fathy O, Elghwalby N, Sultan A, Elebidy E, Abdalla T, Elshobary M, Mostafa M, Foad A, Kandeel T, Abdel Raouf A, Salah T, Abu Zeid M, Abu Elenein A, Gad Elhak N, ElFiky A, Ezzat F. Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepatogastroenterology. 2006 Jan-Feb;53(67):5\u201310. Epub 2006\/03\/02. Cited in: Pubmed; PMID 16506367."},{"key":"3813_CR37","doi-asserted-by":"publisher","unstructured":"Belghiti J, Ogata S. Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma. HPB (Oxford). 2005;7(4):252\u20133. Epub 2008\/03\/12. https:\/\/doi.org\/10.1080\/13651820500372335. Cited in: Pubmed; PMID 18333201.","DOI":"10.1080\/13651820500372335"},{"key":"3813_CR38","doi-asserted-by":"publisher","unstructured":"Li CX, Zhang H, Wang K, Wang X, Li XC. Preoperative Bilirubin Level Predicts Overall Survival and Tumor Recurrence After Resection for Perihilar Cholangiocarcinoma Patients. Cancer Manag Res. 2019;11:10157\u201310165. Epub 2019\/12\/11. https:\/\/doi.org\/10.2147\/CMAR.S230620. Cited in: Pubmed; PMID 31819648.","DOI":"10.2147\/CMAR.S230620"},{"key":"3813_CR39","doi-asserted-by":"publisher","unstructured":"Xu S, Zhang XP, Zhao GD, Zhao ZM, Gao YX, Hu MG, Tan XL, Liu R. Development and validation of an online calculator to predict early recurrence and long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2022 Nov;29(11):1214\u20131225. Epub 2021\/10\/23. https:\/\/doi.org\/10.1002\/jhbp.1058. Cited in: Pubmed; PMID 34676993.","DOI":"10.1002\/jhbp.1058"},{"key":"3813_CR40","doi-asserted-by":"publisher","unstructured":"Sallinen V, Siren J, Makisalo H, Lehtimaki TE, Lantto E, Kokkola A, Nordin A. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas. Scand J Surg. 2020 Sep;109(3):219\u2013227. Epub 2019\/02\/23. https:\/\/doi.org\/10.1177\/1457496919832150. Cited in: Pubmed; PMID 30791825.","DOI":"10.1177\/1457496919832150"},{"key":"3813_CR41","doi-asserted-by":"publisher","unstructured":"Wellner UF, Shen Y, Keck T, Jin W, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival. Surg Today. 2017 Mar;47(3):271\u2013279. Epub 2016\/05\/30. https:\/\/doi.org\/10.1007\/s00595-016-1362-0. Cited in: Pubmed; PMID 27236779.","DOI":"10.1007\/s00595-016-1362-0"},{"key":"3813_CR42","doi-asserted-by":"publisher","unstructured":"Andrianello S, Paiella S, Allegrini V, Ramera M, Pulvirenti A, Malleo G, Salvia R, Bassi C. Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up. Langenbecks Arch Surg. 2015 Jul;400(5):623\u20138. Epub 2015\/07\/03. https:\/\/doi.org\/10.1007\/s00423-015-1320-0. Cited in: Pubmed; PMID 26134446.","DOI":"10.1007\/s00423-015-1320-0"},{"key":"3813_CR43","doi-asserted-by":"publisher","unstructured":"Guilbaud T, Girard E, Lemoine C, Schlienger G, Alao O, Risse O, Berdah S, Chirica M, Moutardier V, Birnbaum DJ. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis? Updates Surg. 2021 Apr;73(2):439\u2013450. Epub 2021\/01\/25. https:\/\/doi.org\/10.1007\/s13304-021-00981-0. Cited in: Pubmed; PMID 33486711.","DOI":"10.1007\/s13304-021-00981-0"},{"key":"3813_CR44","doi-asserted-by":"publisher","unstructured":"Lyu S, Li L, Zhao X, Ren Z, Cao D, He Q. Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy. World J Surg Oncol. 2020 Oct 8;18(1):262. Epub 2020\/10\/10. https:\/\/doi.org\/10.1186\/s12957-020-02040-1. Cited in: Pubmed; PMID 33032609.","DOI":"10.1186\/s12957-020-02040-1"},{"key":"3813_CR45","doi-asserted-by":"publisher","unstructured":"Maeta T, Ebata T, Hayashi E, Kawahara T, Mizuno S, Matsumoto N, Ohta S, Nagino M, Nagoya Surgical Oncology G. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma. Br J Surg. 2017 Oct;104(11):1549\u20131557. Epub 2017\/08\/08. https:\/\/doi.org\/10.1002\/bjs.10596. Cited in: Pubmed; PMID 28782798.","DOI":"10.1002\/bjs.10596"},{"key":"3813_CR46","doi-asserted-by":"publisher","unstructured":"Liu J, Wu P, Lai S, Wang J, Hou H, Zhang Y. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning. BMC Cancer. 2023 Jun 22;23(1):574. Epub 2023\/06\/23. https:\/\/doi.org\/10.1186\/s12885-023-11058-z. Cited in: Pubmed; PMID 37349696.","DOI":"10.1186\/s12885-023-11058-z"},{"key":"3813_CR47","doi-asserted-by":"publisher","unstructured":"Zhao F, Yang D, He J, Ju X, Ding Y, Li X. Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma. Front Oncol. 2022;12:1007538. Epub 2022\/12\/13. https:\/\/doi.org\/10.3389\/fonc.2022.1007538. Cited in: Pubmed; PMID 36505787.","DOI":"10.3389\/fonc.2022.1007538"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03813-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03813-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03813-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:02:06Z","timestamp":1745499726000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03813-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03813-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5958306\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Ethics Committee of Beijing Chao-Yang Hospital (No. 2020-D- 301) and individual consent for this retrospective analysis was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}